We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$166M
AUM Growth
+$4.72M
Cap. Flow
+$4.91M
Cap. Flow %
2.96%
Top 10 Hldgs %
72.14%
Holding
622
New
62
Increased
177
Reduced
49
Closed
35

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$1.4M
2
NEO icon
NeoGenomics
NEO
+$1.27M
3
CNTA
Centessa Pharmaceuticals
CNTA
+$882K
4
ATEC icon
Alphatec Holdings
ATEC
+$582K
5
TRV icon
Travelers Companies
TRV
+$549K

Top Sells

Rank Stock Value
1
MODN
MODEL N, INC.
MODN
+$1.03M
2
TELA icon
TELA Bio
TELA
+$980K
3
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$535K
4
IWM icon
iShares Russell 2000 ETF
IWM
+$319K
5
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$82.3K

Sector Composition

Rank Sector Weight
1 Healthcare 10.57%
2 Financials 4.94%
3 Technology 3.85%
4 Industrials 1.42%
5 Consumer Staples 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBKR icon
351
Interactive Brokers
IBKR
$40.5B
$6.42K ﹤0.01%
208
-96
-32% -$2.86K
MCO icon
352
Moody's
MCO
$83.9B
$6.31K ﹤0.01%
15
– –
CTAS icon
353
Cintas
CTAS
$86B
$6.3K ﹤0.01%
36
– –
SHW icon
354
Sherwin-Williams
SHW
$87.4B
$6.27K ﹤0.01%
21
– –
BMRN icon
355
BioMarin Pharmaceuticals
BMRN
$12B
$6.17K ﹤0.01%
75
– –
PYPL icon
356
PayPal
PYPL
$51.4B
$6.09K ﹤0.01%
105
– –
DJT icon
357
Trump Media & Technology Group
DJT
$2.74B
$6.06K ﹤0.01%
185
– –
NKE icon
358
Nike
NKE
$63.9B
$6.05K ﹤0.01%
130
+50
+63% +$4.65K
TMDX icon
359
Transmedics
TMDX
$2.64B
$6.03K ﹤0.01%
40
– –
INSP icon
360
Inspire Medical Systems
INSP
$1.5B
$6.02K ﹤0.01%
+45
New +$8.52K
ARKW icon
361
ARK Web x.0 ETF
ARKW
$1.64B
$6.01K ﹤0.01%
77
– –
ASPN icon
362
Aspen Aerogels
ASPN
$364M
$5.96K ﹤0.01%
250
– –
MLM icon
363
Martin Marietta Materials
MLM
$35B
$5.96K ﹤0.01%
11
– –
EBAY icon
364
eBay
EBAY
$52.1B
$5.89K ﹤0.01%
110
+1
+0.9% +$52
GNTX icon
365
Gentex
GNTX
$5.12B
$5.85K ﹤0.01%
173
– –
TKO icon
366
TKO Group
TKO
$13.9B
$5.83K ﹤0.01%
54
– –
BALL icon
367
Ball Corp
BALL
$17.8B
$5.76K ﹤0.01%
96
-35
-27% -$2.34K
SNDL icon
368
Sundial Growers
SNDL
$318M
$5.7K ﹤0.01%
3,000
– –
XNCR icon
369
Xencor
XNCR
$1.48B
$5.68K ﹤0.01%
300
– –
AAL icon
370
American Airlines Group
AAL
$10.2B
$5.67K ﹤0.01%
500
– –
TWO
371
Two Harbors Investment
TWO
$1.27B
$5.6K ﹤0.01%
424
+15
+4% +$191
RBLX icon
372
Roblox
RBLX
$35.4B
$5.58K ﹤0.01%
150
– –
PH icon
373
Parker-Hannifin
PH
$125B
$5.56K ﹤0.01%
11
– –
FFNW
374
DELISTED
First Financial Northwest, Inc
FFNW
$5.53K ﹤0.01%
262
+2
+0.8% +$42
NBIX icon
375
Neurocrine Biosciences
NBIX
$18.4B
$5.51K ﹤0.01%
40
-20
-33% -$2.74K
13 14
15
16 17

Similar funds

PPA
Pilgrim Partners Asia Singapore $246M AUM
IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return

HighMark Wealth Management's Q2 2024 Portfolio in Review

As of Q2 2024, HighMark Wealth Management held 622 positions worth $166M, up 2.9% from $161M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

HighMark Wealth Management's Q2 2024 filing shows 62 new, 177 increased, 49 reduced and 35 closed positions. Its largest new stake was Centessa Pharmaceuticals: 93,000 shares worth $840K. The largest sale was MODEL N, INC., an estimated $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.1% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q2 2024 buy was Centessa Pharmaceuticals: 93,000 shares worth $840K.
  • HighMark Wealth Management added most to AtriCure in Q2 2024, an estimated $1.4M increase.
  • HighMark Wealth Management's biggest Q2 2024 reduction was TELA Bio, cutting an estimated $980K.
  • HighMark Wealth Management fully exited MODEL N, INC. in Q2 2024, selling an estimated $1.03M.
  • HighMark Wealth Management's ten largest holdings make up 72% of its $166M portfolio in Q2 2024.
  • HighMark Wealth Management opened 62 new positions and closed 35 in Q2 2024.
  • HighMark Wealth Management's portfolio value rose 2.9% quarter-over-quarter to $166M.

Based on HighMark Wealth Management's 13F filing for Q2 2024, filed 29 Jul 2024.